Dr Jeffrey Hill
performed his doctoral research at Cardiff University in the field of aspartic proteinases where he developed an interest in drug discovery for tropical diseases. After completing a WHO funded post-doctoral project on Plasmodial proteinases he relocated to Thailand and was involved in the characterisation of proteinases from a number of viruses including dengue. On returning to Europe he began work for SmithKlineBeecham Pharmaceuticals which then became GlaxoSmithKline Pharmaceuticals. During his time at GSK he worked in both the Discovery Research and the Genetics Research Divisions where he was involved in many aspects of target validation, assay development and biomarker discovery.
In 2006 Jeffrey returned to South East Asia and began working for the Agency for Science, Technology and Research (A*Star) Singapore, first in the Bioinformatics Institute and then in the Experimental Therapeutics Centre. Currently he is a member of the Senior Management Team, Head of Biology and Group Leader of the Protein Biochemistry and Analytics Group.